The Asia-Pacific (APAC) region has emerged as one of the fastest-growing hubs for healthcare innovation, biopharmaceutical development, and medical technology adoption. Rapid population growth, rising healthcare expenditures, and expanding access to advanced treatments have fueled the need for data-driven decision-making across the sector. As a result, healthcare market research firms play a crucial role in guiding pharmaceutical companies, medical device manufacturers, healthcare investors, and policy stakeholders through the region’s complex landscape.
This article highlights the Top 10 Healthcare Market Research Firms in APAC, recognized for their robust methodology, industry expertise, and high-impact insights. Each organization brings unique strengths that help stakeholders navigate challenges, identify opportunities, and strengthen strategic planning across the region.
IQVIA is arguably the most influential healthcare market research and analytics firm operating in the APAC region. With expansive proprietary datasets, advanced analytics platforms, and deep regional presence, IQVIA supports pharmaceutical and biotech companies throughout the product lifecycle—from clinical development and regulatory planning to commercialization and real-world evidence generation.
The firm’s strength lies in its combination of technology and healthcare expertise. IQVIA’s vast network across Japan, China, India, Singapore, South Korea, and Australia positions it as a go-to partner for navigating complex regulatory systems and diverse market dynamics.
Frost & Sullivan is widely recognized for its strategic insights and industry analysis across a broad spectrum of healthcare segments, including medical devices, digital health, hospital infrastructure, diagnostics, and biotechnology. The firm maintains a strong research footprint across Southeast Asia, India, China, and Australia.
Its growth opportunity analysis, competitive benchmarking, and innovation-focused studies offer valuable direction for companies seeking to strengthen their market positioning, assess emerging technologies, or expand into new APAC markets.
Kantar Health brings a strong evidence-based approach to healthcare market intelligence. The firm specializes in epidemiology, patient insights, oncology research, and health economics. Known for its comprehensive data capabilities and advanced analytics, Kantar Health provides deep insights into patient experiences and market access trends within the APAC context.
Its presence in China, Japan, South Korea, and Southeast Asia allows clients to tap into nuanced regional insights that support both global and localized decision-making.
DelveInsight is a leading healthcare-focused market research and consulting company known for its robust drug intelligence, epidemiology analyses, and pipeline assessments. The firm offers a strong portfolio of reports and consulting solutions tailored to pharmaceutical companies, biotech innovators, and healthcare investors.
In the APAC region, DelveInsight is well-regarded for its therapeutic-area expertise, actionable forecasting, and in-depth evaluations of emerging and established markets. Its strengths lie in analyzing disease burden, competitive landscapes, and clinical development trends—making it a strategic partner for organizations seeking clear visibility into opportunities and risks across the region.
GlobalData Healthcare is a major force in data-driven market analysis, offering end-to-end insights spanning drugs, devices, clinical trials, healthcare providers, and regulatory landscapes. The firm leverages machine learning and proprietary intelligence platforms to deliver precise market forecasting and competitive intelligence.
GlobalData’s APAC-oriented reports and consulting engagements help organizations understand evolving trends, including healthcare digitization, government policy shifts, and patient demographics across China, India, Australia, and Southeast Asia.
Ipsos Healthcare is known for its deep expertise in patient and physician insights, brand strategy research, and behavioral studies. Its strong presence in APAC markets enables it to capture culturally relevant perspectives, making it invaluable for companies that require robust qualitative and quantitative market insights.
Ipsos Healthcare supports a wide array of therapeutic areas and is particularly noted for its work in oncology, immunology, rare diseases, and chronic conditions. Companies rely on its insights to refine marketing strategies, improve patient engagement, and optimize brand performance.
NielsenIQ has a well-established reputation for retail analytics and consumer behavior research. Its healthcare division applies these strengths to OTC (over-the-counter) medicines, medical supplies, consumer health products, and pharmacy retail dynamics across APAC.
For organizations looking to understand purchasing behavior, monitor product performance, or assess healthcare consumption patterns, NielsenIQ delivers real-time insights via robust data collection and modern analytical tools.
MarketsandMarkets has expanded rapidly in the APAC healthcare research space, offering comprehensive syndicated reports and custom studies covering pharmaceuticals, biotechnology, diagnostics, medical devices, digital health, and hospital technologies. The firm leverages a powerful market data platform that integrates industry intelligence, revenue forecasts, and competitive analysis.
Known for its forward-looking research, MarketsandMarkets enables companies to identify high-growth opportunities and anticipate market shifts across the region’s dynamic healthcare ecosystem.
Research & Markets is a globally recognized research aggregator that offers extensive healthcare-focused reports relevant to APAC markets. The firm collaborates with regional experts, research partners, and industry specialists to compile data on pharmaceuticals, medical devices, diagnostics, telehealth, and public health trends.
Its broad report portfolio and accessibility make it a practical resource for companies looking for quick, reliable insights into emerging and established healthcare segments throughout the region.
Grand View Research has gained prominence in the APAC market due to its detailed industry reports and market modeling capabilities. The firm covers a wide array of healthcare topics, including biotechnology, clinical diagnostics, medical imaging, precision medicine, and digital therapeutics.
With a strong emphasis on forecast accuracy and market segmentation, Grand View Research supports businesses seeking long-term investment insights and strategic clarity in the fast-evolving APAC healthcare market.